| |
| Trade Name | CARDIOSEAL SEPTAL OCCLUSION SYSTEM |
| Classification Name | transcatheter septal occluder |
| Generic Name | transcatheter septal occluder |
| Applicant |
| Nitinol Medical Technologies, Inc. |
| 27 wormwood st. |
| boston, MA 02210 |
|
| HDE Number | H990011 |
| Supplement Number | S011 |
| Date Received | 04/02/2004 |
| Decision Date | 05/10/2004 |
| Product Code | |
| Advisory Committee |
Cardiovascular |
| Supplement Type | special (immediate track) |
| Supplement Reason | labeling change - indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
Approval Order Statement Addition of a warning to the labeling that protamine sulfate should not beused for heparin reversal because of the potential for thrombus formation. |